IntelGenX: Funding, Investors & Team (Sep 2026)
Based on its unique VersaFilmTM technology platform, IntelGenx is a firm that specialises in the development and production of new pharmaceutical oral films for oral medication administration. It offers complete pharmaceutical services, including R&D, analytical method development, clinical monitoring, IP protection, and regulatory services, to pharmaceutical partners. Designed for the VersaFilmTM technology platform, IntelGenx's cutting-edge manufacturing facility supports production at all scales, from lab to pilot to commercial, and provides complete service capabilities to its customers.
IntelGenX has raised $3.0M across 1 funding round on record, the most recent an undisclosed round of $3.0M announced in Jan 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
IntelGenX Company Profile and Key Stats
Latest funding round on record: Jan 2023.
IntelGenX Funding Rounds
IntelGenX Founders and Leadership Team
No contact details are on record for this team yet.
IntelGenX Funding Compared to Other Biotechnology Startups
IntelGenX's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like IntelGenX in Biotechnology and Saint Laurent
Companies Similar to IntelGenX
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
IntelGenX Funding FAQs
What does IntelGenX do?
Based on its unique VersaFilmTM technology platform, IntelGenx is a firm that specialises in the development and production of new pharmaceutical oral films for oral medication administration. It offers complete pharmaceutical services, including R&D, analytical method development, clinical monitoring, IP protection, and regulatory services, to pharmaceutical partners. Designed for the VersaFilmTM technology platform, IntelGenx's cutting-edge manufacturing facility supports production at all scales, from lab to pilot to commercial, and provides complete service capabilities to its customers.
How much funding has IntelGenX raised?
IntelGenX has raised $3.0M across 1 round on record. The most recent is an undisclosed round of $3.0M announced in Jan 2023.
When did IntelGenX last raise funding?
IntelGenX's most recent funding round on record is an undisclosed round of $3.0M, announced in Jan 2023.
Who is the CEO of IntelGenX?
Horst G Zerbe is listed as CEO at IntelGenX.
Where is IntelGenX headquartered?
IntelGenX is based in Saint Laurent, Quebec, Canada.
How many employees does IntelGenX have?
IntelGenX is in the 11-50 employee band.
How does IntelGenX's funding compare to other Biotechnology startups?
IntelGenX's latest round of $3.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's IntelGenX Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for IntelGenX is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.